How to Obtain AMA
PRA Category 1
Credit™
- Listen to the CME audio discussion.
- Take the CME posttest.
- Login to your account.
- Complete the registration / evaluation form.
- Print your personalized
CME certificate.
Rheumatology
Online CME
Survey
|
|
|
Rheumatoid Arthritis and Malignancy: Associations, Effects of Treatment,
and Discussion of Options for Patients with Prior Cancer |
|
| Release Date: October 30, 2008 |
Renewal Date: November 12, 2009 |
Expiration Date: May 12, 2010 |
Technical Requirements
(will appear in new window)
| Estimated Time of Completion |
1 hour |
| Description / Overview |
The purpose of this activity is to examine the risk of malignancy in patients with rheumatoid arthritis (RA), clarify the association of malignancy and treatment for RA, and determine treatment options for a patient with RA who has a history of lymphoma. |
| Objectives |
At the conclusion of this activity, the participant will be able to:
- Explain the relative risks for specific malignancies in patients with RA.
- Review safety data concerning malignancy and the use of disease-modifying antirheumatic drugs (DMARDs) or biologics in patients with RA.
- Discuss treatment options for a patient with RA who has a history of lymphoma.
|
| Target Audience |
This activity is directed to rheumatologists and primary care physicians who treat patients with RA. |
| Accreditation |
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit. |
| Activity Director |
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, Ohio |
| Author / Faculty |
Kevin M. Latinis, MD, PhD
Department of Internal Medicine
Division of Allergy, Clinical Immunology, and Rheumatology
University of Kansas Medical Center
Kansas City, Kansas |
| Faculty Disclosure |
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:
| Leonard Calabrese, DO |
| |
Consulting: |
Abbott Laboratories;
Elan Pharmaceuticals, Inc.;
Genentech, Inc.; Roche Laboratories, Inc. |
| |
| |
Teaching
and Speaking: |
Genentech, Inc. |
| |
| Kevin M. Latinis, MD, PhD |
| |
Consulting: |
Genentech, Inc. |
| |
| |
Teaching
and Speaking: |
Genentech, Inc. |
|
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:
Bristol – Myers Squibb Company, Genentech/Biogen Idec
Wyeth Pharmaceuticals
This CME activity was produced by
The Cleveland Clinic Foundation
Center for Continuing Education and DIME.
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
|
